Skip to main content

Advertisement

SpringerLink
Log in

MiR-374a Activates Wnt/β-Catenin Signaling to Promote Osteosarcoma Cell Migration by Targeting WIF-1

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

MiR-374a was proved to take part in the initiation and development of several cancers. However, the molecular mechanism of miR-374a in osteosarcoma (OS) cells remains unclear. The aim of our research was to investigate the role of miR-374a in OS cells migration and clarify the potential mechanisms. Quantitative real-time PCR (qRT-PCR) and western blot analysis were applied to evaluate the expression of miR-374a and Wnt inhibitory factor-1 (WIF-1). Bioinformatical methods and luciferase reporter assay were carried out to predict and confirm the combination of miR-374a and WIF-1. Transwell and wound healing assays were performed to detect the migration capacity of OS cells. Lithium chloride (LiCl) was used to investigate the role of LiCl-activated Wnt/β-catenin signaling pathway in regulating cell migration. Our studies revealed that miR-374a was up-regulated whereas WIF-1 was down-regulated in OS cells. Besides, WIF-1 was the target of miR-374a by performing luciferase reporter assay. By transfection of miR-374a inhibitor and/or WIF-1 siRNA to OS cells, we found that miR-374a promoted the migration of OS cells. In addition, the inhibition of WIF-1 abolished the miR-374a inhibitor-induced migration suppression of OS cells. LiCl experiment revealed that miR-374a promoted OS cells migration by regulating Wnt/β-catenin signaling. In conclusion, miR-374a promotes OS cells migration by activating Wnt/β-catenin signaling pathway via targeting WIF-1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Misaghi A, Goldin A, Awad M, Kulidjian AA (2018) Osteosarcoma: a comprehensive review. SICOT J 4:12

    Article  Google Scholar 

  2. Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, Kuijjer ML, Serra M, Burger H, Cleton-Jansen AM, Myklebost O (2012) Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 7:e48086

    Article  Google Scholar 

  3. Kumar R, Kumar M, Malhotra K, Patel S (2018) Primary osteosarcoma in the elderly revisited: current concepts in diagnosis and treatment. Curr Oncol Rep 20:13

    Article  Google Scholar 

  4. Simpson S, Dunning MD, de Brot S, Grau-Roma L, Mongan NP, Rutland CS (2017) Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics. Acta Vet Scand 59:71

    Article  Google Scholar 

  5. Zhang Y, Yang Q, Wang S (2014) MicroRNAs: a new key in lung cancer. Cancer Chemother Pharmacol 74:1105–1111

    Article  CAS  Google Scholar 

  6. Yang X, Wang L, Wang Q, Li L, Fu Y, Sun J (2018) MiR-183 inhibits osteosarcoma cell growth and invasion by regulating LRP6-Wnt/beta-catenin signaling pathway. Biochem Biophys Res Commun 496:1197–1203

    Article  CAS  Google Scholar 

  7. Yang Z, Li X, Yang Y, He Z, Qu X, Zhang Y (2016) Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma. Cell Death Dis 7:e2389

    Article  CAS  Google Scholar 

  8. Chen Y, Jiang J, Zhao M, Luo X, Liang Z, Zhen Y, Fu Q, Deng X, Lin X, Li L (2016) microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway. Oncotarget 7:41306–41319

    PubMed  PubMed Central  Google Scholar 

  9. Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan J, Wu J, Li M (2013) MicroRNA-374a activates Wnt/beta-catenin signaling to promote breast cancer metastasis. J Clin Invest 123:566–579

    Article  CAS  Google Scholar 

  10. Wang Y, Xin H, Han Z, Sun H, Gao N, Yu H (2015) MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression. Oncol Rep 34:1988–1994

    Article  CAS  Google Scholar 

  11. Lee SH, Koo BS, Kim JM, Huang S, Rho YS, Bae WJ, Kang HJ, Kim YS, Moon JH, Lim YC (2014) Wnt/beta-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. J Pathol 234:99–107

    Article  CAS  Google Scholar 

  12. Mohammed MK, Shao C, Wang J, Wei Q, Wang X, Collier Z, Tang S, Liu H, Zhang F, Huang J, Guo D, Lu M, Liu F, Liu J, Ma C, Shi LL, Athiviraham A, He TC, Lee MJ (2016) Wnt/beta-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis 3:11–40

    Article  CAS  Google Scholar 

  13. Yang F, Zeng Q, Yu G, Li S, Wang CY (2006) Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal 18:679–687

    Article  CAS  Google Scholar 

  14. Lin B, Hong H, Jiang X, Li C, Zhu S, Tang N, Wang X, She F, Chen Y (2017) WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival. Gene 622:42–49

    Article  CAS  Google Scholar 

  15. Tang Q, Zhao H, Yang B, Li L, Shi Q, Jiang C, Liu H (2017) WIF-1 gene inhibition and Wnt signal transduction pathway activation in NSCLC tumorigenesis. Oncol Lett 13:1183–1188

    Article  CAS  Google Scholar 

  16. Malinauskas T, Aricescu AR, Lu W, Siebold C, Jones EY (2011) Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol 18:886–893

    Article  CAS  Google Scholar 

  17. Huang Y, Du Q, Wu W, She F, Chen Y (2016) Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins. Mol Med Rep 14:2573–2581

    Article  CAS  Google Scholar 

  18. Ma Y, Zhu B, Liu X, Yu H, Yong L, Liu X, Shao J, Liu Z (2015) Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/beta-catenin signaling pathway. J Exp Clin Cancer Res 34:115

    Article  Google Scholar 

  19. Yu M, Guo D, Cao Z, Xiao L, Wang G (2018) Inhibitory effect of MicroRNA-107 on osteosarcoma malignancy through regulation of Wnt/beta-catenin signaling in vitro. Cancer Investig 36:175–184

    Article  CAS  Google Scholar 

  20. Jiang Z, Jiang C, Fang J (2018) Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/beta-catenin pathway. Biochem Biophys Res Commun 495:238–245

    Article  CAS  Google Scholar 

  21. Poos K, Smida J, Maugg D, Eckstein G, Baumhoer D, Nathrath M, Korsching E (2015) Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules. PLoS One 10:e0123082

    Article  Google Scholar 

  22. Li X, Lu Q, Xie W, Wang Y, Wang G (2018) Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt/beta-catenin signaling. Biochem Biophys Res Commun 496:443–449

    Article  CAS  Google Scholar 

  23. He W, Feng L, Xia D, Han N (2014) MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression. Int J Clin Exp Med 8:3482–3489

    Google Scholar 

  24. Yiyu Chen JJ, Zhao M, Luo X, Liang Z, Zhen Y, Qiaofen F, Deng X, Lin X, Li L, Luo R, Liu Z, Fang W (2016) microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway. Oncotarget 7:41306–41319

    PubMed  PubMed Central  Google Scholar 

  25. Vosa U, Vooder T, Kolde R, Fischer K, Valk K, Tonisson N, Roosipuu R, Vilo J, Metspalu A, Annilo T (2011) Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes Cancer 50:812–822

    Article  CAS  Google Scholar 

  26. Wei B, Guo Y, Zhai J, Su J, Han L, Kang C, Zhang Q (2013) A study of the relationship between the Wnt/beta-catenin signaling pathway and the gastrointestinal development of rat embryonic and perinatal periods. Exp Ther Med 5:1598–1602

    Article  Google Scholar 

  27. Tang L, Wang D, Gu D (2018) Knockdown of Sox2 inhibits OS cells invasion and migration via modulating Wnt/beta-catenin signaling pathway. Pathol Oncol Res 24:907–913

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported the Development Program of Kunming University of Science and Technology (Grant No.: KKSY201560051), Yunnan Provincial Science and Technology Department-Kunming Medical University Joint Special Project (Grant No.: 2015FB095) and the Basic Research Project of Yunnan Provincial Science and Technology (Grant No.: 2018FB119).

Author information

Authors and Affiliations

  1. Faculty of Medical Science, Kunming University of Science and Technology, Kunming, 650500, China

    Weichao Li

  2. Department of Orthopedic Surgery, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, No. 157 Jinbi Road, Kunming, 650032, China

    Weichao Li, Zengdong Meng, Tiannan Zou, Gang Wang, Yijing Su, Shaoping Yao & Xianrun Sun

Authors
  1. Weichao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zengdong Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tiannan Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yijing Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shaoping Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xianrun Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Shaoping Yao or Xianrun Sun.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, W., Meng, Z., Zou, T. et al. MiR-374a Activates Wnt/β-Catenin Signaling to Promote Osteosarcoma Cell Migration by Targeting WIF-1. Pathol. Oncol. Res. 26, 533–539 (2020). https://doi.org/10.1007/s12253-018-0556-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-018-0556-8

Keywords

Search

Navigation